Transparency Market
Research (TMR) has published a new report titled “Addiction
Treatment Market – Global Industry Analysis, Size, Share, Growth,
Trends, and Forecast, 2017–2025”. According to the report, the
global addiction treatment market was valued at approximately US$ 4.0
Bn in 2016 is projected to expand at a CAGR of over 6.0% from 2017 to
2025. The report suggests that growing abuse of prescription drugs
and favorable reimbursements for smoking cessation therapy are likely
to spur demand for addiction treatment market in the near future
(2017 to 2025). North America and Western Europe are likely to
account for dominant share of the global addiction treatment market
due to introduction of new drugs by key players. Government
initiative to spread awareness about drug addiction in emerging
markets such as China and India is likely to boost the addiction
treatment market in Asia Pacific. The market in the region is
anticipated to expand at a CAGR of around 7.0% from 2017 to 2025.
Request for
Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40199
The report offers
detailed segmentation of the global addiction treatment market based
on treatment type, drug type, treatment center, and distribution
channels. In terms of treatment type, the tobacco/nicotine addiction
treatment segment accounts for a leading share of the global market
during the forecast period. Higher share of the tobacco/nicotine
addiction treatment segment is attributed to high adoption and wide
availability of various over-the-counter nicotine replacement
products used to combat tobacco and nicotine addiction. Opioid
addiction treatment segment is likely to expand at a comparatively
higher growth rate during the forecast period due to increase in
usage of illicit drugs.
The report offers
detailed segmentation of the global addiction treatment market based
on drug type. The nicotine replacement products segment is poised to
account for a leading share of the global market during the forecast
period. Expansion of the segment is due to rise in the number of
smokers across the globe and this has increased concerns about health
risks for both smokers and passive smokers. The Varenicline drug
segment is anticipated to lose market share during the forecast
period due to side effects such as stomach pain, sleep disorder, and
diarrhea. The segment accounted for market share of approximately
21.3% in 2016 and is expected to reach 21.2% by 2025.
Based on treatment
center, the outpatient treatment segment is projected to hold a
dominant share of global addiction market during the forecast period.
It is likely to expand at a CAGR of more than 6.0% from 2017 to 2025.
Outpatient treatment centers less restrictive and less expensive.
These factors are likely to drive the segment during the forecast
period. Additionally, in outpatient center, an addiction patient
usually requires to spend less time in the center for treatment. This
helps those who unable to give extended time for treatments. In terms
of value, the inpatient treatment center segment accounted for more
than 18.0% share of the global addiction treatment market in 2016. It
is anticipated to account for approximately 19.0% share of the market
by 2025.
Enquiry for
discount on this report @
In terms of value,
North America dominated the global addiction treatment market in
2016. Rise in awareness regarding different opioid treatment programs
and increase in government initiatives to raise awareness about
substance abuse, ill effects of drug, and importance of abuse
treatment are propelling the addiction treatment market in North
America. Rise in health care spending in emerging markets such as
China and India is fueling the addiction treatment market in Asia
Pacific. Economic growth in countries such as Brazil in Latin
American is boosting health care expenditure through rise in private
health insurance, entry of international drug manufacturers, and
health care providers in the region. This is likely to propel the
addiction treatment market in Latin America to expand at a CAGR of
7.1% from 2017 to 2025.
The report also
provides profiles of leading players such as Allergan plc,
GlaxoSmithKline plc, Purdue Pharma L.P., Mallinckrodt, Hikma
Pharmaceuticals PLC, Orexo AB, and Reckitt Benckiser (Indivior PLC)
that operate in the global addiction treatment market. Expansion of
addiction treatment portfolio through improving existing drugs and
developing new drug molecules is one of the key strategy adopted by
many key players. Moreover, company’s focuses on strategic
partnership to expand their business in various regions. For
instance, recently, Orexo AB plans to launch Zuvsolv in new markets
through its partner MundiPharma.
About Us
Transparency Market
Research (TMR) is a market intelligence company, providing global
business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers. TMR’s experienced team of
analysts, researchers, and consultants, use proprietary data sources
and various tools and techniques to gather, and analyze information.
Our business offerings represent the latest and the most reliable
information indispensable for businesses to sustain a competitive
edge.
Each TMR syndicated
research report covers a different sector - such as pharmaceuticals,
chemicals, energy, food & beverages, semiconductors, med-devices,
consumer goods and technology. These reports provide in-depth
analysis and deep segmentation to possible micro levels. With wider
scope and stratified research methodology, TMR’s syndicated reports
strive to provide clients to serve their overall research
requirement.
US Office
Contact
90 State Street,
Suite 700
Albany, NY 12207
Tel:
+1-518-618-1030
USA - Canada Toll
Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment